Lakefront Biotherapeutics (LKFT) Times Interest Earned (2016 - 2026)
Lakefront Biotherapeutics (LKFT) posted quarterly Times Interest Earned of $464.99 for Q1 2026, up 128.53% year-on-year from $203.47 in Q1 2025, and up 88.09% on a QoQ basis from $247.21 in Q4 2025.
Lakefront Biotherapeutics (LKFT) Times Interest Earned (2016 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has reported Times Interest Earned for 11 consecutive years, with $464.99 the latest figure, recorded in Q1 2026.
- Quarterly Times Interest Earned rose 128.53% year-over-year to $464.99 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $352.98 (up 175.54% YoY) and the FY2025 annual result came in at $285.34, up 238.17% from the prior year.
- Times Interest Earned grew to $464.99 in Q1 2026 per LKFT's latest filing, from $247.21 in the prior quarter.
- Over the last five years, Times Interest Earned for LKFT reached as high as $464.99 in Q1 2026 and fell as low as $0.16 in Q4 2022.
- A 5-year average of $167.2 and a median of $197.44 in 2025 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2023 — Times Interest Earned soared 48990.5% — and 2024, when it tumbled 38.31%.
- Year by year, Times Interest Earned stood at $0.16 in 2022, then surged by 48990.5% to $76.89 in 2023, then slumped by 38.31% to $47.44 in 2024, then jumped by 421.11% to $247.21 in 2025, then surged by 88.09% to $464.99 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered $464.99, $247.21, and $197.44 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Lakefront Biotherapeutics | 1.85 Bn | -1.64 Bn | 1.91 Mn | 464.99 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 464.99 |
| Dec 31, 2025 | 247.21 |
| Sep 30, 2025 | 197.44 |
| Jun 30, 2025 | 306.97 |
| Mar 31, 2025 | 203.47 |
| Dec 31, 2024 | 47.44 |
| Sep 30, 2024 | 271.97 |
| Jun 30, 2024 | 270.47 |
| Mar 31, 2024 | 76.69 |
| Dec 31, 2023 | 76.89 |
| Mar 31, 2023 | 4.82 |
| Dec 31, 2022 | 0.16 |
| Mar 31, 2022 | 5.03 |
| Jun 30, 2021 | 5.74 |
| Mar 31, 2021 | 4.48 |
| Jun 30, 2020 | 37.02 |
| Mar 31, 2020 | 1.86 |
| Dec 31, 2019 | -11.79 |
| Sep 30, 2019 | -10.17 |
| Jun 30, 2019 | 30.14 |